CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 256 filers reported holding CYTOKINETICS INC in Q3 2023. The put-call ratio across all filers is 2.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,509,383 | -7.7% | 51,235 | +2.2% | 0.01% | 0.0% |
| Q2 2023 | $1,635,795 | +1.9% | 50,147 | +9.9% | 0.01% | -9.1% |
| Q1 2023 | $1,605,227 | -23.0% | 45,616 | +0.2% | 0.01% | -26.7% |
| Q4 2022 | $2,085,039 | -6.2% | 45,505 | -0.8% | 0.02% | -6.2% |
| Q3 2022 | $2,222,000 | +26.4% | 45,853 | +2.5% | 0.02% | +33.3% |
| Q2 2022 | $1,758,000 | +4.3% | 44,744 | -2.3% | 0.01% | +33.3% |
| Q1 2022 | $1,685,000 | -23.9% | 45,774 | -5.7% | 0.01% | -18.2% |
| Q4 2021 | $2,214,000 | +23.6% | 48,563 | -3.1% | 0.01% | +10.0% |
| Q3 2021 | $1,791,000 | +103.1% | 50,099 | +12.5% | 0.01% | +233.3% |
| Q2 2021 | $882,000 | -14.9% | 44,549 | -0.1% | 0.00% | -25.0% |
| Q1 2021 | $1,037,000 | +10.7% | 44,584 | -1.1% | 0.00% | +33.3% |
| Q4 2020 | $937,000 | -6.3% | 45,097 | -2.4% | 0.00% | -40.0% |
| Q3 2020 | $1,000,000 | +6.3% | 46,190 | +15.7% | 0.01% | 0.0% |
| Q2 2020 | $941,000 | +106.8% | 39,923 | +3.4% | 0.01% | +150.0% |
| Q1 2020 | $455,000 | +5.8% | 38,621 | -4.7% | 0.00% | 0.0% |
| Q4 2019 | $430,000 | -9.1% | 40,524 | -2.6% | 0.00% | 0.0% |
| Q3 2019 | $473,000 | +1.5% | 41,608 | +0.5% | 0.00% | 0.0% |
| Q2 2019 | $466,000 | +61.2% | 41,395 | +15.7% | 0.00% | +100.0% |
| Q1 2019 | $289,000 | +24.6% | 35,768 | -2.6% | 0.00% | 0.0% |
| Q4 2018 | $232,000 | -36.6% | 36,712 | -1.2% | 0.00% | 0.0% |
| Q3 2018 | $366,000 | +22.4% | 37,159 | +3.2% | 0.00% | 0.0% |
| Q2 2018 | $299,000 | +56.5% | 36,015 | +35.6% | 0.00% | 0.0% |
| Q1 2018 | $191,000 | -31.3% | 26,556 | -22.2% | 0.00% | 0.0% |
| Q4 2017 | $278,000 | -43.6% | 34,135 | +0.5% | 0.00% | -50.0% |
| Q3 2017 | $493,000 | +28.4% | 33,976 | +7.1% | 0.00% | +100.0% |
| Q2 2017 | $384,000 | +43.3% | 31,711 | +52.1% | 0.00% | 0.0% |
| Q1 2017 | $268,000 | +13.1% | 20,852 | +7.1% | 0.00% | 0.0% |
| Q4 2016 | $237,000 | -99.9% | 19,472 | -0.3% | 0.00% | 0.0% |
| Q3 2016 | $179,221,000 | -3.1% | 19,523 | +0.1% | 0.00% | 0.0% |
| Q2 2016 | $184,998,000 | +25.0% | 19,494 | -7.3% | 0.00% | 0.0% |
| Q1 2016 | $148,000,000 | -33.0% | 21,040 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $221,000,000 | +156637.6% | 21,040 | -0.5% | 0.00% | 0.0% |
| Q3 2015 | $141,000 | -99.9% | 21,136 | -2.2% | 0.00% | 0.0% |
| Q2 2015 | $145,233,000 | -14.1% | 21,612 | -13.3% | 0.00% | 0.0% |
| Q1 2015 | $169,066,000 | -3.0% | 24,936 | +14.6% | 0.00% | 0.0% |
| Q4 2014 | $174,242,000 | +118.9% | 21,753 | -3.8% | 0.00% | – |
| Q3 2014 | $79,601,000 | -26.4% | 22,614 | -0.1% | 0.00% | – |
| Q2 2014 | $108,176,000 | -37.1% | 22,631 | +25.0% | 0.00% | -100.0% |
| Q1 2014 | $172,026,000 | +49.8% | 18,108 | +2.5% | 0.00% | 0.0% |
| Q4 2013 | $114,875,000 | -8.8% | 17,673 | +6.4% | 0.00% | 0.0% |
| Q3 2013 | $126,017,000 | – | 16,603 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $6,580,834 | 7.72% |
| Finepoint Capital LP | 431,693 | $12,717,676 | 6.33% |
| Saturn V Capital Management LP | 495,168 | $14,587,649 | 6.11% |
| Logos Global Management LP | 1,250,000 | $36,825,000 | 4.91% |
| DAFNA Capital Management LLC | 479,538 | $14,127,189 | 4.39% |
| PFM Health Sciences, LP | 2,399,545 | $70,690,596 | 3.33% |
| Boxer Capital, LLC | 2,100,000 | $61,866,000 | 3.29% |
| Integral Health Asset Management, LLC | 800,000 | $23,568,000 | 3.26% |
| GREAT POINT PARTNERS LLC | 600,000 | $17,676,000 | 3.22% |
| Nicholas Investment Partners, LP | 942,137 | $27,755,356 | 2.07% |